Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
PTC Therapeutics, Inc. (PTCT)  
$33.62 0.54 (1.58%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,552,000
Market Cap: 3.04(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.07 - $59.1
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8
Insider 3/6 Months : 8.6
Guru Rank Number :  538
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 7,700 7,700 7,700
Total Buy Value $0 $198,736 $198,736 $198,736
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 5,981 52,172 114,858 280,340
Total Sell Value $151,224 $1,447,501 $4,819,149 $12,887,777
Total People Sold 3 8 10 15
Total Sell Transactions 4 26 35 88
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 524
  Page 9 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Okey Stephanie Director   –       •      –    2021-08-13 4 S $40.06 $66,094 D/D (1,650) 963 -5%     
   Boulding Mark Elliott Exec. VP and CLO   •       –      –    2021-07-09 4 AS $45.00 $64,306 D/D (1,429) 48,374 -13%     
   Boulding Mark Elliott Exec. VP and CLO   •       –      –    2021-07-09 4 OE $18.01 $25,736 D/D 1,429 48,618     -
   Boulding Mark Elliott Exec. VP and CLO   •       –      –    2021-07-08 4 AS $45.20 $352,968 D/D (7,805) 48,374 -12%     
   Boulding Mark Elliott Exec. VP and CLO   •       –      –    2021-07-08 4 OE $11.23 $127,008 D/D 7,805 49,779     -
   Smith Mary L. Director   –       •      –    2021-06-11 4 A $0.00 $0 D/D 2,613 2,613     -
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-06-11 4 A $0.00 $0 I/I 6,240 22,721     -
   Graham Dawn Director   –       •      –    2021-06-09 4 S $41.89 $15,288 D/D (365) 27,065 9%     
   Klein Matthew B. Chief Development Officer   •       –      –    2021-04-20 4 AS $46.58 $76,704 D/D (1,641) 16,809 -9%     
   Pauwels Eric Chief Business Officer   •       –      –    2021-04-19 4 S $48.17 $37,860 D/D (786) 35,701 15%     
   Klein Matthew B. Chief Development Officer   •       –      –    2021-04-19 4 AS $48.17 $41,376 D/D (859) 18,450 -15%     
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-04-13 4 A $0.00 $0 I/I 1,400 16,481     -
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-02-08 4 AS $66.00 $175,362 D/D (2,657) 16,509 -30%     
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-02-08 4 OE $33.02 $87,734 D/D 2,657 19,166     -
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-02-02 4 AS $57.64 $37,581 D/D (652) 16,509 -27%     
   Utter Christine Marie SVP, Finance & CAO   •       –      –    2021-02-01 4 AS $56.96 $20,960 D/D (368) 17,161 -24%     
   Pauwels Eric Chief Business Officer   •       –      –    2021-02-01 4 S $56.96 $20,618 D/D (362) 36,487 24%     
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-02-01 4 S $56.96 $16,119 I/I (283) 15,081 24%     
   Peltz Stuart Walter Chief Executive Officer   •       •      –    2021-02-01 4 S $56.96 $112,089 D/D (1,968) 80,315 24%     
   Graham Dawn Director   –       •      –    2021-02-01 4 S $56.96 $28,820 D/D (506) 27,430 24%     
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-02-01 4 S $56.96 $1,595 I/I (28) 1,819 24%     
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-02-01 4 S $56.96 $55,418 D/D (973) 35,814 24%     
   Boulding Mark Elliott Exec. VP and CLO   •       –      –    2021-02-01 4 S $56.96 $44,312 D/D (778) 48,374 24%     
   Hill Emily Luisa Chief Financial Officer   •       –      –    2021-02-01 4 S $56.96 $30,813 D/D (541) 23,306 24%     
   Almstead Neil Gregory Chief Technical Ops Officer   •       –      –    2021-01-25 4 AS $62.05 $34,166 I/I (541) 1,847 -38%     
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us